πŸ‡ΊπŸ‡Έ FDA
Patent

US 8865722

Wet formulations of aripiprazole

granted A61KA61K31/496A61K9/1623

Quick answer

US patent 8865722 (Wet formulations of aripiprazole) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/496, A61K9/1623, A61K9/1652, A61K9/2018